Closely spaced multiple mutations as potential signatures of transient hypermutability in human genes

Human Mutation

Volumn 30, Issue 10, 2009, Pages 1435-1448

  Chen, Jian Min ^a,b,c,d   Férec, Claude ^a,b,c,d,e   Cooper, David N ^f  

^a INSERM   (France)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

^c FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

^d Institut Federatif de Recherche IFR 148   (France)

^e CHU MORVAN   (France)

^f CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

CpG mutation hotspot; Csmms; Human inherited disease; Multiple mutations; Mutational mechanisms; Transient hypermutability

Indexed keywords

ARTICLE; HUMAN; MUTATION; RETROSPECTIVE STUDY;

HUMANS; MUTATION; RETROSPECTIVE STUDIES;

EID: 73349129387     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.21088     Document Type: Article

References (173)

1. Abdalla SA, Pece-Barbara N, Vera S, Tapia E, Paez E, Bernabeu C, Letarte M. 2000. Analysis of ALK-1 and endoglin in newborns from families with hereditary hemorrhagic telangiectasia type 2. Hum Mol Genet 9:1227-1237.
2. Abdelghaffar TY, Elsayed SM, Elsobky E, Bochow B, Buttner J, Schmidt H. 2008. Mutational analysis of ATP7B gene in Egyptian children with Wilson disease: 12 novel mutations. J Hum Genet 53:681-687.
3. Adato A, Kalinski H, Weil D, Chaib H, Korostishevsky M, Bonne-Tamir B. 1999. Possible interaction between USH1B and USH3 gene products as implied by apparent digenic deafness inheritance. Am J Hum Genet 65:261-265.
4. Ainsworth PJ, Coulter-Mackie MB. 1992. A double mutation in exon 6 of the betahexosaminidase alpha subunit in a patient with the B1 variant of Tay-Sachs disease. Am J Hum Genet 51:802-809.
5. Akagi R, Yasui Y, Harper P, Sassa S. 1999. A novel mutation of delta-aminolaevulinate dehydratase in a healthy child with 12% erythrocyte enzyme activity. Br J Haematol 106:931-937.
6. Aldred MJ, Talacko AA, Savarirayan R, Murdolo V, Mills AE, Radden BG, Alimov A, Villablanca A, Larsson C. 2006. Dental findings in a family with hyperparathyroidism-jaw tumor syndrome and a novel HRPT2 gene mutation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101:212-218.
7. Antonarakis SE, Cooper DN. 2007. Mutations in human genetic disease. Nature and consequences. In Rimoin DL, Connor JM, Pyeritz RE, Korf BR, editors. Principles and practice of medical genetics, 5th ed. Edinburgh: Churchill Livingstone. p 101-128.
8. Arana ME, Takata K, Garcia-Diaz M, Wood RD, Kunkel TA. 2007. A unique error signature for human DNA polymerase n. DNA Repair (Amst) 6:213-223.
9. Ashley N, Adams S, Slama A, Zeviani M, Suomalainen A, Andreu AL, Naviaux RK, Poulton J. 2007. Defects in maintenance of mitochondrial DNA are associated with intramitochondrial nucleotide imbalances. Hum Mol Genet 16:1400-1411.
10. Azuma N, Hotta Y, Tanaka H, Yamada M. 1998. Missense mutations in the PAX6 gene in aniridia. Invest Ophthalmol Vis Sci 39:2524-2528.
11. Bach G, Moskowitz SM, Tieu PT, Matynia A, Neufeld EF. 1993. Molecular analysis of Hurler syndrome in Druze and Muslim Arab patients in Israel: multiple allelic mutations of the IDUA gene in a small geographic area. Am J Hum Genet 53:330-338.
12. Balbi P, Seri M, Ceccherini I, Uggetti C, Casale R, Fundaro C, Caroli F, Santoro L. 2008. Adult-onset Alexander disease: report on a family. J Neurol 255:24-30.
13. Barnett LB, Tyl RW, Shane BS, Shelby MD, Lewis SE. 2002. Transmission of mutations in the lacI transgene to the offspring of ENU-treated Big Blue male mice. Environ Mol Mutagen 40:251-257.
14. Bascom RA, Liu L, Heckenlively JR, Stone EM, McInnes RR. 1995. Mutation analysis of the ROM1 gene in retinitis pigmentosa. Hum Mol Genet 4:1895-1902.
15. Batelli S, Albani D, Prato F, Polito L, Franceschi M, Gavazzi A, Forloni G. 2008. Earlyonset Alzheimer disease in an Italian family with presenilin-1 double mutation E318G and G394V. Alzheimer Dis Assoc Disord 22:184-187.
16. Batra VK, Beard WA, Shock DD, Pedersen LC, Wilson SH. 2008. Structures of DNA polymerase beta with active-site mismatches suggest a transient abasic site intermediate during misincorporation. Mol Cell 30:315-324.
17. Beard WA, Osheroff WP, Prasad R, Sawaya MR, Jaju M, Wood TG, Kraut J, Kunkel TA, Wilson SH. 1996. Enzyme-DNA interactions required for efficient nucleotide incorporation and discrimination in human DNA polymerase beta. J Biol Chem 271:12141-12144.
18. Bendahhou S, Cummins TR, Hahn AF, Langlois S, Waxman SG, Ptacek LJ. 2000. A double mutation in families with periodic paralysis defines new aspects of sodium channel slow inactivation. J Clin Invest 106:431-438.
19. Benn DE, Croxson MS, Tucker K, Bambach CP, Richardson AL, Delbridge L, Pullan PT, Hammond J, Marsh DJ, Robinson BG. 2003. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas. Oncogene 22:1358-1364.
20. Berg T, Riise HM, Hansen GM, Malm D, Tranebjaerg L, Tollersrud OK, Nilssen O. 1999. Spectrum of mutations in alpha-mannosidosis. Am J Hum Genet 64:77-88.
21. Bernot A, da Silva C, Petit JL, Cruaud C, Caloustian C, Castet V, Ahmed-Arab M, Dross C, Dupont M, Cattan D, Smaoui N, Dode C, Pecheux C, Nedelec B, Medaxian J, Rozenbaum M, Rosner I, Delpech M, Grateau G, Demaille J, Weissenbach J, Touitou I. 1998. Non-founder mutations in the MEFV gene establish this gene as the cause of familial Mediterranean fever (FMF). Hum Mol Genet 7:1317-1325.
22. Bienfait HM, Baas F, Gabreels-Festen AA, Koelman JH, Langerhorst CT, de Visser M. 2002. Two amino-acid substitutions in the myelin protein zero gene of a case of Charcot-Marie-Tooth disease associated with light-near dissociation. Neuromuscul Disord 12:281-285.
23. Biguzzi E, Razzari C, Lane DA, Castaman G, Cappellari A, Bucciarelli P, Fontana G, Margaglione M, D'Andrea G, Simmonds RE, Rezende SM, Preston R, Prisco D, Faioni EM. 2005. Molecular diversity and thrombotic risk in protein S deficiency: the PROSIT study. Hum Mutat 25:259-269.
24. Bonizzato A, Russo MP, Donini M, Dusi S. 1997. Identification of a double mutation (D160V-K161E) in the p67phox gene of a chronic granulomatous disease patient. Biochem Biophys Res Commun 231:861-863.
25. Bovill EG, Tomczak JA, Grant B, Bhushan F, Pillemer E, Rainville IR, Long GL. 1992. Protein C Vermont: symptomatic type II protein C deficiency associated with two GLA domain mutations. Blood 79:1456-1465.
26. Braun A, Ambach H, Kammerer S, Rolinski B, Stöckler S, Rabl W, Gartner J, Zierz S, Roscher AA. 1995. Mutations in the gene for X-linked adrenoleukodystrophy in patients with different clinical phenotypes. Am J Hum Genet 56:854-861.
27. Buettner VL, Hill KA, Scaringe WA, Sommer SS. 2000. Evidence that proximal multiple mutations in Big Blue transgenic mice are dependent events. Mutat Res 452:219-229.
28. Burwinkel B, Maichele AJ, Aagenaes O, Bakker HD, Lerner A, Shin YS, Strachan JA, Kilimann MW. 1997. Autosomal glycogenosis of liver and muscle due to phosphorylase kinase deficiency is caused by mutations in the phosphorylase kinase beta subunit (PHKB). Hum Mol Genet 6:1109-1115.
29. Cassidy AJ, van Steensel MA, Steijlen PM, van Geel M, van der Velden J, Morley SM, Terrinoni A, Melino G, Candi E, McLean WH. 2005. A homozygous missense mutation in TGM5 abolishes epidermal transglutaminase 5 activity and causes acral peeling skin syndrome. Am J Hum Genet 77:909-917.
30. Cazeneuve C, Sarkisian T, Pecheux C, Dervichian M, Nedelec B, Reinert P, Ayvazyan A, Kouyoumdjian JC, Ajrapetyan H, Delpech M, Goossens M, Dode C, Grateau G, Amselem S. 1999. MEFV-Gene analysis in armenian patients with Familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications. Am J Hum Genet 65:88-97.
31. Cazzola M, Bergamaschi G, Tonon L, Arbustini E, Grasso M, Vercesi E, Barosi G, Bianchi PE, Cairo G, Arosio P. 1997. Hereditary hyperferritinemia-cataract syndrome: relationship between phenotypes and specific mutations in the ironresponsive element of ferritin light-chain mRNA. Blood 90:814-821.
32. Chen JM, Chuzhanova N, Stenson PD, Férec C, Cooper DN. 2005a. Complex gene rearrangements caused by serial replication slippage. Hum Mutat 26:125-134.
33. Chen JM, Chuzhanova N, Stenson PD, Férec C, Cooper DN. 2005b. Intrachromosomal serial replication slippage in trans gives rise to diverse genomic rearrangements involving inversions. Hum Mutat 26:362-373.
34. Chen JM, Chuzhanova N, Stenson PD, Férec C, Cooper DN. 2005c. Meta-analysis of gross insertions causing human genetic disease: novel mutational mechanisms and the role of replication slippage. Hum Mutat 25:207-221.
35. Chen JM, Cooper DN, Chuzhanova N, Férec C, Patrinos GP. 2007. Gene conversion: mechanisms, evolution and human disease. Nat Rev Genet 8:762-775.
36. Chen JM, Férec C, Cooper DN. 2006. A systematic analysis of disease-associated variants in the 30 regulatory regions of human protein-coding genes II: the importance of mRNA secondary structure in assessing the functionality of 30 UTR variants. Hum Genet 120:301-333.
37. Chen Z, Feng J, Buzin CH, Sommer SS. 2008. Epidemiology of doublet/multiplet mutations in lung cancers: evidence that a subset arises by chronocoordinate events. PLoS ONE 3:e3714.
38. Chuzhanova N, Chen JM, Bacolla A, Patrinos GP, Férec C, Wells RD, Cooper DN. 2009. Gene conversion causing human inherited disease: evidence for involvement of non-B-DNA-forming sequences and recombination-promoting motifs in DNA breakage and repair. Hum Mutat 2009 Mar 18. [Epub ahead of print].
39. Colgin LM, Hackmann AF, Emond MJ, Monnat Jr RJ. 2002. The unexpected landscape of in vivo somatic mutation in a human epithelial cell lineage. Proc Natl Acad Sci USA 99:1437-1442.
40. Crabbe RA, Prtenjaca A, Tarnowski HE, Hill KA. 2008. A novel germline mutation in Big Blues mice. Environ Mol Mutagen 50:114-120.
41. Dawson PA, Cox AJ, Emmerson BT, Dudman NP, Kraus JP, Gordon RB. 1997. Characterisation of five missense mutations in the cystathionine beta-synthase gene from three patients with B6-nonresponsive homocystinuria. Eur J Hum Genet 5:15-21.
42. de Franchis R, Kozich V, McInnes RR, Kraus JP. 1994. Identical genotypes in siblings with different homocystinuric phenotypes: identification of three mutations in cystathionine beta-synthase using an improved bacterial expression system. Hum Mol Genet 3:1103-1108.
43. De Luca A, Torrente I, Mangino M, Danesi R, Dallapiccola B, Novelli G. 2001. Three novel mutations causing a truncated protein within the RP2 gene in Italian families with X-linked retinitis pigmentosa. Mutat Res 432:79-82.
44. Drake JW. 2007a. Mutations in clusters and showers. Proc Natl Acad Sci USA 104:8203-8204.
45. Drake JW. 2007b. Too many mutants with multiple mutations. Crit Rev Biochem Mol Biol 42:247-258.
46. Drake JW, Bebenek A, Kissling GE, Peddada S. 2005. Clusters of mutations from transient hypermutability. Proc Natl Acad Sci USA 102:12849-12854.
47. Dupradeau FY, Pissard S, Coulhon MP, Cadet E, Foulon K, Fourcade C, Goossens M, Case DA, Rochette J. 2008. An unusual case of hemochromatosis due to a new compound heterozygosity in HFE (p.[Gly43Asp;His63Asp]1[Cys282Tyr]): structural implications with respect to binding with transferrin receptor 1. Hum Mutat 29:206.
48. Elango N, Kim SH, Vigoda E, Yi SV. 2008. Mutations of different molecular origins exhibit contrasting patterns of regional substitution rate variation. PLoS Comput Biol 4:e1000015.
49. Eng CM, Niehaus DJ, Enriquez AL, Burgert TS, Ludman MD, Desnick RJ. 1994. Fabry disease: twenty-three mutations including sense and antisense CpG alterations and identification of a deletional hot-spot in the alpha-galactosidase A gene. Hum Mol Genet 3:1795-1799.
50. Finette BA, Homans AC, Albertini RJ. 2000. Emergence of genetic instability in children treated for leukemia. Science 288:514-517.
51. Fremeaux-Bacchi V, Moulton EA, Kavanagh D, Dragon-Durey MA, Blouin J, Caudy A, Arzouk N, Cleper R, Francois M, Guest G, Pourrat J, Seligman R, Fridman WH, Loirat C, Atkinson JP. 2006. Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome. J Am Soc Nephrol 17:2017-2025.
52. Grace ME, Balwani M, Nazarenko I, Prakash-Cheng A, Desnick RJ. 2007. Type 1 Gaucher disease: null and hypomorphic novel chitotriosidase mutationsimplications for diagnosis and therapeutic monitoring. Hum Mutat 28: 866-873.
53. Gudayol M, Vidal J, Usac EF, Morales A, Fabregat ME, Fernandez-Checa JC, Novials A, Gomis R. 2001. Identification and functional analysis of mutations in FAD-binding domain of mitochondrial glycerophosphate dehydrogenase in Caucasian patients with type 2 diabetes mellitus. Endocrine 16:39-42.
54. Guis S, Figarella-Branger D, Monnier N, Bendahan D, Kozak-Ribbens G, Mattei JP, Lunardi J, Cozzone PJ, Pellissier JF. 2004. Multiminicore disease in a family susceptible to malignant hyperthermia: histology, in vitro contracture tests, and genetic characterization. Arch Neurol 61:106-113.
55. Guldberg P, Henriksen KF, Guttler F. 1993. Molecular analysis of phenylketonuria in Denmark: 99% of the mutations detected by denaturing gradient gel electrophoresis. Genomics 17:141-146.
56. Guo C, Van Damme B, Vanrenterghem Y, Devriendt K, Cassiman JJ, Marynen P. 1995. Severe alport phenotype in a woman with two missense mutations in the same COL4A5 gene and preponderant inactivation of the X chromosome carrying the normal allele. J Clin Invest 95:1832-1837.
57. Harnevik L, Fjellstedt E, Molbaek A, Tiselius HG, Denneberg T, Söderkvist P. 2001. Identification of 12 novel mutations in the SLC3A1 gene in Swedish cystinuria patients. Hum Mutat 18:516-525.
58. Hashiguchi T, Yotsumoto S, Shimada H, Terasaki K, Setoyama M, Kobayashi K, Saheki T, Kanzaki T. 2002. A novel point mutation in the keratin 17 gene in a Japanese case of pachyonychia congenita type 2. J Invest Dermatol 118:545-547.
59. Hasselbacher K, Wiggins RC, Matejas V, Hinkes BG, Mucha B, Hoskins BE, Ozaltin F, Nürnberg G, Becker C, Hangan D, Pohl M, Kuwertz-Broking E, Griebel M, Schumacher V, Royer-Pokora B, Bakkaloglu A, Nurnberg P, Zenker M, Hildebrandt F. 2006. Recessive missense mutations in LAMB2 expand the clinical spectrum of LAMB2-associated disorders. Kidney Int 70:1008-1012.
60. Havndrup O, Bundgaard H, Andersen PS, Larsen LA, Vuust J, Kjeldsen K, Christiansen M. 2000. A novel missense mutation, Leu390Val, in the cardiac beta-myosin heavy chain associated with pronounced septal hypertrophy in two families with hypertrophic cardiomyopathy. Scand Cardiovasc J 34:558-563.
61. Hendig D, Schulz V, Eichgrun J, Szliska C, Götting C, Kleesiek K. 2005. New ABCC6 gene mutations in German pseudoxanthoma elasticum patients. J Mol Med 83:140-147.
62. Hermos CR, Huizing M, Kaiser-Kupfer MI, Gahl WA. 2002. Hermansky-Pudlak syndrome type 1: gene organization, novel mutations, and clinical-molecular review of non-Puerto Rican cases. Hum Mutat 20:482.
63. Hill KA, Wang J, Farwell KD, Scaringe WA, Sommer SS. 2004. Spontaneous multiple mutations show both proximal spacing consistent with chronocoordinate events and alterations with p53-deficiency. Mutat Res 554:223-240.
64. Hill KA, Wang J, Farwell KD, Sommer SS. 2003. Spontaneous tandem-base mutations (TBM) show dramatic tissue, age, pattern and spectrum specificity. Mutat Res 534:173-186.
65. Hinney A, Schmidt A, Nottebom K, Heibült O, Becker I, Ziegler A, Gerber G, Sina M, Görg T, Mayer H, Siegfried W, Fichter M, Remschmidt H, Hebebrand J. 1999. Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans. J Clin Endocrinol Metab 84:1483-1486.
66. Hiroi N, Yakushiji F, Shimojo M, Watanabe S, Sugano S, Yamaguchi N, Miyachi Y. 1998. Human ACTH hypersensitivity syndrome associated with abnormalities of the ACTH receptor gene. Clin Endocrinol (Oxf) 48:129-134.
67. Hoedemaekers YM, Caliskan K, Majoor-Krakauer D, van de Laar I, Michels M, Witsenburg M, ten Cate FJ, Simoons ML, Dooijes D. 2007. Cardiac beta-myosin heavy chain defects in two families with non-compaction cardiomyopathy: linking non-compaction to hypertrophic, restrictive, and dilated cardiomyopathies. Eur Heart J 28:2732-2737.
68. Holm IA, Huang X, Kunkel LM. 1997. Mutational analysis of the PEX gene in patients with X-linked hypophosphatemic rickets. Am J Hum Genet 60:790-797.
69. Hrebicek M, Mrazova L, Seyrantepe V, Durand S, Roslin NM, Noskova L, Hartmannova H, Ivanek R, Cizkova A, Poupetova H, Sikora J, Urinovska J, Stranecky V, Zeman J, Lepage P, Roquis D, Verner A, Ausseil J, Beesley CE, Maire I, Poorthuis BJ, van de Kamp J, van Diggelen OP, Wevers RA, Hudson TJ, Fujiwara TM, Majewski J, Morgan K, Kmoch S, Pshezhetsky AV. 2006. Mutations in TMEM76* cause mucopolysaccharidosis IIIC (Sanfilippo C syndrome). Am J Hum Genet 79:807-819.
70. Hu Z, Bonifas JM, Beech J, Bench G, Shigihara T, Ogawa H, Ikeda S, Mauro T, Epstein Jr EH. 2000. Mutations in ATP2C1, encoding a calcium pump, cause Hailey-Hailey disease. Nat Genet 24:61-65.
71. Igarashi T, Minami M, Nishida Y. 1989. Molecular analysis of hypoxanthine-guanine phosphoribosyltransferase mutations in five unrelated Japanese patients. Acta Paediatr Jpn 31:303-313.
72. Ishii S, Sakuraba H, Suzuki Y. 1992. Point mutations in the upstream region of the alpha-galactosidase A gene exon 6 in an atypical variant of Fabry disease. Hum Genet 89:29-32.
73. Ito S, Nakamura M, Nuno Y, Ohnishi Y, Nishida T, Miyake Y. 2004. Novel complex GUCY2D mutation in Japanese family with cone-rod dystrophy. Invest Ophthalmol Vis Sci 45:1480-1485.
74. Jacobson DR, Buxbaum JN. 1994. A double-variant transthyretin allele (Ser 6, Ile 33) in the Israeli patient "SKO" with familial amyloidotic polyneuropathy. Hum Mutat 3:254-260.
75. Jeru I, Duquesnoy P, Fernandes-Alnemri T, Cochet E, Yu JW, Lackmy-Port-Lis M, Grimprel E, Landman-Parker J, Hentgen V, Marlin S, McElreavey K, Sarkisian T, Grateau G, Alnemri ES, Amselem S. 2008. Mutations in NALP12 cause hereditary periodic fever syndromes. Proc Natl Acad Sci USA 105:1614-1619.
76. Jiang C, Hong R, Horowitz SD, Kong X, Hirschhorn R. 1997. An adenosine deaminase (ADA) allele contains two newly identified deleterious mutations (Y97C and L106V) that interact to abolish enzyme activity. Hum Mol Genet 6:2271-2278.
77. Jones B, Jones EL, Bonney SA, Patel HN, Mensenkamp AR, Eichenbaum-Voline S, Rudling M, Myrdal U, Annesi G, Naik S, Meadows N, Quattrone A, Islam SA, Naoumova RP, Angelin B, Infante R, Levy E, Roy CC, Freemont PS, Scott J, Shoulders CC. 2003. Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders. Nat Genet 34:29-31.
78. Kelberman D, Rizzoti K, Avilion A, Bitner-Glindzicz M, Cianfarani S, Collins J, Chong WK, Kirk JM, Achermann JC, Ross R, Carmignac D, Lovell-Badge R, Robinson IC, Dattani MT. 2006. Mutations within Sox2/SOX2 are associated with abnormalities in the hypothalamo-pituitary-gonadal axis in mice and humans. J Clin Invest 116:2442-2455.
79. Kim CH, Zabetian CP, Cubells JF, Cho S, Biaggioni I, Cohen BM, Robertson D, Kim KS. 2002. Mutations in the dopamine beta-hydroxylase gene are associated with human norepinephrine deficiency. Am J Med Genet 108:140-147.
80. Kimbell LM, Ohno K, Engel AG, Rotundo RL. 2004. C-terminal and heparin-binding domains of collagenic tail subunit are both essential for anchoring acetylcholinesterase at the synapse. J Biol Chem 279:10997-11005.
81. Klupa T, Warram JH, Antonellis A, Pezzolesi M, Nam M, Malecki MT, Doria A, Rich SS, Krolewski AS. 2002. Determinants of the development of diabetes (maturity-onset diabetes of the young-3) in carriers of HNF-1alpha mutations: evidence for parent-of-origin effect. Diabetes Care 25:2292-2301.
82. Knebelmann B, Breillat C, Forestier L, Arrondel C, Jacassier D, Giatras I, Drouot L, Deschenes G, Grunfeld JP, Broyer M, Gubler MC, Antignac C. 1996. Spectrum of mutations in the COL4A5 collagen gene in X-linked Alport syndrome. Am J Hum Genet 59:1221-1232.
83. Kotze MJ, de Villiers JN, Loubser O, Thiart R, Scholtz CL, Raal FJ. 1997. A double mutant LDL receptor allele in a Cypriot family with heterozygous familial hypercholesterolemia. Hum Genet 100:101-103.
84. Kou K, Lajara R, Rotwein P. 1993. Amino acid substitutions in the intracellular part of the growth hormone receptor in a patient with the Laron syndrome. J Clin Endocrinol Metab 76:54-59.
85. Kouwaki M, Hamajima N, Sumi S, Nonaka M, Sasaki M, Dobashi K, Kidouchi K, Togari H, Wada Y. 1998. Identification of novel mutations in the dihydropyrimidine dehydrogenase gene in a Japanese patient with 5-fluorouracil toxicity. Clin Cancer Res 4:2999-3004.
86. Kress W, Schropp C, Lieb G, Petersen B, Busse-Ratzka M, Kunz J, Reinhart E, Schafer WD, Sold J, Hoppe F, Pahnke J, Trusen A, Sorensen N, Krauss J, Collmann H. 2006. Saethre-Chotzen syndrome caused by TWIST1 gene mutations: functional differentiation from Muenke coronal synostosis syndrome. Eur J Hum Genet 14:39-48.
87. Krijanovski Y, Proulle V, Mahdi F, Dreyfus M, Muller-Esterl W, Schmaier AH. 2003. Characterization of molecular defects of Fitzgerald trait and another novel highmolecular-weight kininogen-deficient patient: insights into structural requirements for kininogen expression. Blood 101:4430-4436.
88. Lamantea E, Zeviani M. 2004. Sequence analysis of familial PEO shows additional mutations associated with the 752C-T and 3527C-T changes in the POLG1 gene. Ann Neurol 56:454-455.
89. Lanzerath K, Bettendorf M, Haag C, Kneppo C, Schulze E, Grulich-Henn J. 2006. Screening for Pax8 mutations in patients with congenital hypothyroidism in South-West Germany. Horm Res 66:96-100.
90. Laporte J, Guiraud-Chaumeil C, Vincent MC, Mandel JL, Tanner SM, Liechti-Gallati S, Wallgren-Pettersson C, Dahl N, Kress W, Bolhuis PA, Fardeau M, Samson F, Bertini E. 1997. Mutations in the MTM1 gene implicated in X-linked myotubular myopathy. ENMC International Consortium on Myotubular Myopathy. European Neuro-Muscular Center. Hum Mol Genet 6:1505-1511.
91. Le Bizec C, Vuillaumier-Barrot S, Barnier A, Dupre T, Durand G, Seta N. 2005. A new insight into PMM2 mutations in the French population. Hum Mutat 25:504-505.
92. Lee MH, Lu K, Hazard S, Yu H, Shulenin S, Hidaka H, Kojima H, Allikmets R, Sakuma N, Pegoraro R, Srivastava AK, Salen G, Dean M, Patel SB. 2001. Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat Genet 27:79-83.
93. Lee-Chen GJ, Lin SP, Ko MH, Chuang CK, Chen CP, Lee HH, Cheng SC, Shen CH, Tseng KL, Li CL. 2002. Identification and characterization of mutations underlying Sanfilippo syndrome type A (mucopolysaccharidosis type IIIA). Clin Genet 61:192-197.
94. Leoyklang P, Suphapeetiporn K, Wananukul S, Shotelersuk V. 2008. Three novel mutations in the PORCN gene underlying focal dermal hypoplasia. Clin Genet 73:373-379.
95. Levran O, Erlich T, Magdalena N, Gregory JJ, Batish SD, Verlander PC, Auerbach AD. 1997. Sequence variation in the Fanconi anemia gene FAA. Proc Natl Acad Sci USA 94:13051-13056.
96. Marble M, Geraghty MT, de Franchis R, Kraus JP, Valle D. 1994. Characterization of a cystathionine beta-synthase allele with three mutations in cis in a patient with B6 nonresponsive homocystinuria. Hum Mol Genet 3:1883-1886.
97. Matejas V, Al-Gazali L, Amirlak I, Zenker M. 2006. A syndrome comprising childhood-onset glomerular kidney disease and ocular abnormalities with progressive loss of vision is caused by mutated LAMB2. Nephrol Dial Transplant 21:3283-3286.
98. Matsuzawa N, Nagao T, Shimozato K, Niikawa N, Yoshiura KI. 2006. Patched homologue 1 mutations in four Japanese families with basal cell nevus syndrome. J Clin Pathol 59:1084-1086.
99. Matte U, Yogalingam G, Brooks D, Leistner S, Schwartz I, Lima L, Norato DY, Brum JM, Beesley C, Winchester B, Giugliani R, Hopwood JJ. 2003. Identification and characterization of 13 new mutations in mucopolysaccharidosis type I patients. Mol Genet Metab 78:37-43.
100. Matyas G, Arnold E, Carrel T, Baumgartner D, Boileau C, Berger W, Steinmann B. 2006. Identification and in silico analyses of novel TGFBR1 and TGFBR2 mutations in Marfan syndrome-related disorders. Hum Mutat 27:760-769.
101. McLean JW, Elshourbagy NA, Chang DJ, Mahley RW, Taylor JM. 1984. Human apolipoprotein E mRNA. cDNA cloning and nucleotide sequencing of a new variant. J Biol Chem 259:6498-6504.
102. Mehenni H, Resta N, Guanti G, Mota-Vieira L, Lerner A, Peyman M, Chong KA, Aissa L, Ince A, Cosme A, Costanza MC, Rossier C, Radhakrishna U, Burt RW, Picard D. 2007. Molecular and clinical characteristics in 46 families affected with Peutz-Jeghers syndrome. Dig Dis Sci 52:1924-1933.
103. Mersiyanova IV, Ismailov SM, Polyakov AV, Dadali EL, Fedotov VP, Nelis E, Lofgren A, Timmerman V, van Broeckhoven C, Evgrafov OV. 2000. Screening for mutations in the peripheral myelin genes PMP22, MPZ and Cx32 (GJB1) in Russian Charcot-Marie-Tooth neuropathy patients. Hum Mutat 15:340-347.
104. Merx S, Neumaier M, Wagner H, Kirschning CJ, Ahmad-Nejad P. 2007. Characterization and investigation of single nucleotide polymorphisms and a novel TLR2 mutation in the human TLR2 gene. Hum Mol Genet 16:1225-1232.
105. Miyauchi A, Futami H, Hai N, Yokozawa T, Kuma K, Aoki N, Kosugi S, Sugano K, Yamaguchi K. 1999. Two germline missense mutations at codons 804 and 806 of the RET proto-oncogene in the same allele in a patient with multiple endocrine neoplasia type 2B without codon 918 mutation. Jpn J Cancer Res 90:1-5.
106. Moallem HJ, Taningo G, Jiang CK, Hirschhorn R, Fikrig S. 2002. Purine nucleoside phosphorylase deficiency: a new case report and identification of two novel mutations (Gly156A1a and Val217Ile), only one of which (Gly156A1a) is deleterious. Clin Immunol 105:75-80.
107. Mozas P, Cenarro A, Civeira F, Castillo S, Ros E, Pocovi M. 2000. Mutation analysis in 36 unrelated Spanish subjects with familial hypercholesterolemia: identification of 3 novel mutations in the LDL receptor gene. Hum Mutat 15:483-484.
108. Nathans J, Davenport CM, Maumenee IH, Lewis RA, Hejtmancik JF, Litt M, Lovrien E, Weleber R, Bachynski B, Zwas F, Klingaman R, Fishman G. 1989. Molecular genetics of human blue cone monochromacy. Science 245:831-838.
109. Neethirajan G, Krishnadas SR, Vijayalakshmi P, Shashikant S, Sundaresan P. 2004. PAX6 gene variations associated with aniridia in south India. BMC Med Genet 5:9.
110. Nishigaki Y, Marti R, Copeland WC, Hirano M. 2003. Site-specific somatic mitochondrial DNA point mutations in patients with thymidine phosphorylase deficiency. J Clin Invest 111:1913-1921.
111. Ogawa T, Tomatsu S, Fukuda S, Yamagishi A, Rezvi GM, Sukegawa K, Kondo N, Suzuki Y, Shimozawa N, Oru T. 1995. Mucopolysaccharidosis IVA: screening and identification of mutations of the N-acetylgalactosamine-6-sulfate sulfatase gene. Hum Mol Genet 4:341-349.
112. Ozturk M, Chiu CY, Akdeniz N, Jenq SF, Chang SC, Hsa CY, Jap TS. 2006. Two novel mutations in the MEN1 gene in subjects with multiple endocrine neoplasia-1. J Endocrinol Invest 29:523-527.
113. Pals-Rylaarsdam R, Liu G, Brickman W, Duranteau L, Monroe J, El-Awady MK, Gad YZ, Shenker A. 2005. A novel double mutation in the luteinizing hormone receptor in a kindred with familial Leydig cell hypoplasia and male pseudohermaphroditism. Endocr Res 31:307-323.
114. Pasmooij AM, van Zalen S, Nijenhuis AM, Kloosterhuis AJ, Zuiderveen J, Jonkman MF, Pas HH. 2004. A very mild form of non-Herlitz junctional epidermolysis bullosa: BP180 rescue by outsplicing of mutated exon 30 coding for the COL15 domain. Exp Dermatol 13:125-128.
115. Pepe G, Vanegas OC, Rickards O, Giusti B, Comeglio P, Brunelli T, Marcucci R, Prisco D, Gensini GF, Abbate R. 1999. World distribution of the T833C/ 844INS68 CBS in cis double mutation: a reliable anthropological marker. Hum Genet 104:126-129.
116. Perrault I, Rozet JM, Gerber S, Kelsell RE, Souied E, Cabot A, Hunt DM, Munnich A, Kaplan J. 1998. A retGC-1 mutation in autosomal dominant cone-rod dystrophy. Am J Hum Genet 63:651-654.
117. Pitteloud N, Acierno Jr JS, Meysing A, Eliseenkova AV, Ma J, Ibrahimi OA, Metzger DL, Hayes FJ, Dwyer AA, Hughes VA, Yialamas M, Hall JE, Grant E, Mohammadi M, Crowley Jr WF. 2006. Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proc Natl Acad Sci USA 103:6281-6286.
118. Plaschke J, Engel C, Kruger S, Holinski-Feder E, Pagenstecher C, Mangold E, Moeslein G, Schulmann K, Gebert J, von Knebel Doeberitz M, Ruschoff J, Loeffler M, Schackert HK. 2004. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium. J Clin Oncol 22:4486-4494.
119. Poturnajova M, Altanerova V, Kostalova L, Breza J, Altaner C. 2005. Novel germline mutation in the transmembrane region of RET gene close to Cys634Ser mutation associated with MEN 2A syndrome. J Mol Med 83:287-295.
120. Quack I, Vonderstrass B, Stock M, Aylsworth AS, Becker A, Brueton L, Lee PJ, Majewski F, Mulliken JB, Suri M, Zenker M, Mundlos S, Otto F. 1999. Mutation analysis of core binding factor A1 in patients with cleidocranial dysplasia. Am J Hum Genet 65:1268-1278.
121. Quesnel S, Verselis S, Portwine C, Garber J, White M, Feunteun J, Malkin D, Li FP. 1999. p53 compound heterozygosity in a severely affected child with Li-Fraumeni syndrome. Oncogene 18:3970-3978.
122. Raas-Rothschild A, Wanders RJ, Mooijer PA, Gootjes J, Waterham HR, Gutman A, Suzuki Y, Shimozawa N, Kondo N, Eshel G, Espeel M, Roels F, Korman SH. 2002. A PEX6-defective peroxisomal biogenesis disorder with severe phenotype in an infant, versus mild phenotype resembling Usher syndrome in the affected parents. Am J Hum Genet 70:1062-1068.
123. Rall Jr SC, Newhouse YM, Clarke HR, Weisgraber KH, McCarthy BJ, Mahley RW, Bersot TP. 1989. Type III hyperlipoproteinemia associated with apolipoprotein E phenotype E3/3. Structure and genetics of an apolipoprotein E3 variant. J Clin Invest 83:1095-1101.
124. Ranta S, Topcu M, Tegelberg S, Tan H, Ustubutun A, Saatci I, Dufke A, Enders H, Pohl K, Alembik Y, Mitchell WA, Mole SE, Lehesjoki AE. 2004. Variant late infantile neuronal ceroid lipofuscinosis in a subset of Turkish patients is allelic to Northern epilepsy. Hum Mutat 23:300-305.
125. Reifenberger J, Janssen G, Weber RG, Bostrom J, Engelbrecht V, Lichter P, Borchard F, Gobel U, Lenard HG, Reifenberger G. 1998. Primitive neuroectodermal tumors of the cerebral hemispheres in two siblings with TP53 germline mutation. J Neuropathol Exp Neurol 57:179-187.
126. Renieri A, Bruttini M, Galli L, Zanelli P, Neri T, Rossetti S, Turco A, Heiskari N, Zhou J, Gusmano R, Massella L, Banfi G, Scolari F, Sessa A, Rizzoni G, Tryggvason K, Pignatti PF, Savi M, Ballabio A, De Marchi M. 1996. X-linked Alport syndrome: an SSCP-based mutation survey over all 51 exons of the COL4A5 gene. Am J Hum Genet 58:1192-1204.
127. Ribeiro LA, El-Jaick KB, Muenke M, Richieri-Costa A. 2006. SIX3 mutations with holoprosencephaly. Am J Med Genet A 140:2577-2583.
128. Riikonen A, Ikonen E, Sormunen R, Lehto VP, Peltonen L, Jalanko A. 1994. Dissection of the molecular consequences of a double mutation causing a human lysosomal disease. DNA Cell Biol 13:257-264.
129. Rinat C, Wanders RJ, Drukker A, Halle D, Frishberg Y. 1999. Primary hyperoxaluria type I: a model for multiple mutations in a monogenic disease within a distinct ethnic group. J Am Soc Nephrol 10:2352-2358.
130. Romano M, Danek GM, Baralle FE, Mazzotti R, Filocamo M. 2000. Functional characterization of the novel mutation IVS 8 (-11delC) (-14T>A) in the intron 8 of the glucocerebrosidase gene of two Italian siblings with Gaucher disease type I. Blood Cells Mol Dis 26:171-176.
131. Rufenacht UB, Gouya L, Schneider-Yin X, Puy H, Schafer BW, Aquaron R, Nordmann Y, Minder EI, Deybach JC. 1998. Systematic analysis of molecular defects in the ferrochelatase gene from patients with erythropoietic protoporphyria. Am J Hum Genet 62:1341-1352.
132. Rump P, Letteboer TG, Gille JJ, Torringa MJ, Baerts W, van Gestel JP, Verheij JB, van Essen AJ. 2006. Severe complications in a child with achondroplasia and two FGFR3 mutations on the same allele. Am J Med Genet A 140:284-290.
133. Saad FA, Merlini L, Mostacciuolo ML, Danieli GA. 1998. Double missense mutation in exon 41 of the human dystrophin gene detected by double strand conformation analysis. Am J Med Genet 80:99-102.
134. Salipante SJ, Benson KF, Luty J, Hadavi V, Kariminejad R, Kariminejad MH, Rezaei N, Horwitz MS. 2007. Double de novo mutations of ELA2 in cyclic and severe congenital neutropenia. Hum Mutat 28:874-881.
135. Savov A, Angelicheva D, Balassopoulou A, Jordanova A, Noussia-Arvanitakis S, Kalaydjieva L. 1995. Double mutant alleles: are they rare? Hum Mol Genet 4:1169-1171.
136. Schneider-Yin X, Gouya L, Dorsey M, Rufenacht U, Deybach JC, Ferreira GC. 2000. Mutations in the iron-sulfur cluster ligands of the human ferrochelatase lead to erythropoietic protoporphyria. Blood 96:1545-1549.
137. Schwartz IV, Lima LC, Tylee K, Sobrinho RP, Norato DY, Duarte AR, Besley G, Burin MG, Matte U, Giugliani R, Leistner-Segal S. 2006. Further cases of "neighbor" mutations in mucopolysaccharidosis type II. Am J Med Genet A 140:1684-1686.
138. Sege-Peterson K, Chambers J, Page T, Jones OW, Nyhan WL. 1992. Characterization of mutations in phenotypic variants of hypoxanthine phosphoribosyltransferase deficiency. Hum Mol Genet 1:427-432.
139. Sheen VL, Ganesh VS, Topcu M, Sebire G, Bodell A, Hill RS, Grant PE, Shugart YY, Imitola J, Khoury SJ, Guerrini R, Walsh CA. 2004. Mutations in ARFGEF2 implicate vesicle trafficking in neural progenitor proliferation and migration in the human cerebral cortex. Nat Genet 36:69-76.
140. Shoshani T, Berkun Y, Yahav Y, Augarten A, Bashan N, Rivlin Y, Gazit E, Sereth H, Kerem E, Kerem BS. 1993. A new mutation in the CFTR gene, composed of two adjacent DNA alterations, is a common cause of cystic fibrosis among Georgian Jews. Genomics 15:236-237.
141. Silander K, Meretoja P, Juvonen V, Ignatius J, Pihko H, Saarinen A, Wallden T, Herrgard E, Aula P, Savontaus ML. 1998. Spectrum of mutations in Finnish patients with Charcot-Marie-Tooth disease and related neuropathies. Hum Mutat 12:59-68.
142. Sillen A, Anton-Lamprecht I, Braun-Quentin C, Kraus CS, Sayli BS, Ayuso C, Jagell S, Kuster W, Wadelius C. 1998. Spectrum of mutations and sequence variants in the FALDH gene in patients with Sjogren-Larsson syndrome. Hum Mutat 12:377-384.
143. Simsek S, Heyboer H, de Bruijne-Admiraal LG, Goldschmeding R, Cuijpers HT, von dem Borne AE. 1993. Glanzmann's thrombasthenia caused by homozygosity for a splice defect that leads to deletion of the first coding exon of the glycoprotein IIIa mRNA. Blood 81:2044-2049.
144. Song S, Wheeler LJ, Mathews CK. 2003. Deoxyribonucleotide pool imbalance stimulates deletions in HeLa cell mitochondrial DNA. J Biol Chem 278:43893-43896.
145. Soufir N, Meziani R, Lacapere JJ, Bertrand G, Fumeron F, Bourillon A, Gerard B, Descamps V, Crickx B, Ollivaud L, Archimbaud A, Lebbe C, Basset-Seguin N, Saiag P, Grandchamp B. 2005. Association between endothelin receptor B nonsynonymous variants and melanoma risk. J Natl Cancer Inst 97:1297-1301.
146. Sprong T, Roos D, Weemaes C, Neeleman C, Geesing CL, Mollnes TE, van Deuren M. 2006. Deficient alternative complement pathway activation due to factor D deficiency by 2 novel mutations in the complement factor D gene in a family with meningococcal infections. Blood 107:4865-4870.
147. Stasia MJ, Lardy B, Maturana A, Rousseau P, Martel C, Bordigoni P, Demaurex N, Morel F. 2002. Molecular and functional characterization of a new X-linked chronic granulomatous disease variant (X911) case with a double missense mutation in the cytosolic gp91phox C-terminal tail. Biochim Biophys Acta 1586:316-330.
148. Stenson PD, Mort M, Ball EV, Howells K, Phillips AD, Thomas NS, Cooper DN. 2009. The Human Gene Mutation Database: 2008 update. Genome Med 1:13.
149. Stolarski B, Pronicka E, Korniszewski L, Pollak A, Kostrzewa G, Rowinska E, Wlodarski P, Skorka A, Gremida M, Krajewski P, Ploski R. 2006. Molecular background of polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome in a Polish population: novel AIRE mutations and an estimate of disease prevalence. Clin Genet 70:348-354.
150. Stouffs K, Lissens W, Tournaye H, Van Steirteghem A, Liebaers I. 2005. Possible role of USP26 in patients with severely impaired spermatogenesis. Eur J Hum Genet 13:336-340.
151. Stuhrmann M, Dörk T, Frühwirth M, Golla A, Skawran B, Antonin W, Ebhardt M, Loos A, Ellemunter H, Schmidtke J. 1997. Detection of 100% of the CFTR mutations in 63 CF families from Tyrol. Clin Genet 52:240-246.
152. Suzuki N, Suzuki T, Inagaki K, Ito S, Kono M, Fukai K, Takama H, Sato K, Ishikawa O, Abe M, Shimizu H, Kawai M, Horikawa T, Yoshida K, Matsumoto K, Terui T, Tsujioka K, Tomita Y. 2005. Mutation analysis of the ADAR1 gene in dyschromatosis symmetrica hereditaria and genetic differentiation from both dyschromatosis universalis hereditaria and acropigmentatio reticularis. J Invest Dermatol 124:1186-1192.
153. Tajima S, Yamamura T, Menju M, Yamamoto A. 1989. Analysis of apolipoprotein E7 (apolipoprotein E-Suita) gene from a patient with hyperlipoproteinemia. J Biochem 105:249-253.
154. Tessitore A, Sinisi AA, Pasquali D, Cardone M, Vitale D, Bellastella A, Colantuoni V. 1999. A novel case of multiple endocrine neoplasia type 2A associated with two de novo mutations of the RET protooncogene. J Clin Endocrinol Metab 84:3522-3527.
155. Thony B, Neuheiser F, Kierat L, Rolland MO, Guibaud P, Schluter T, Germann R, Heidenreich RA, Duran M, de Klerk JB, Ayling JE, Blau N. 1998. Mutations in the pterin-4alpha-carbinolamine dehydratase (PCBD) gene cause a benign form of hyperphenylalaninemia. Hum Genet 103:162-167.
156. Tian D, Wang Q, Zhang P, Araki H, Yang S, Kreitman M, Nagylaki T, Hudson R, Bergelson J, Chen JQ. 2008. Single-nucleotide mutation rate increases close to insertions/deletions in eukaryotes. Nature 455:105-108.
157. Tomatsu S, Filocamo M, Orii KO, Sly WS, Gutierrez MA, Nishioka T, Serrato OP, Di Natale P, Montano AM, Yamaguchi S, Kondo N, Orii T, Noguchi A. 2004. Mucopolysaccharidosis IVA (Morquio A): identification of novel common mutations in the N-acetylgalactosamine-6-sulfate sulfatase (GALNS) gene in Italian patients. Hum Mutat 24:187-188.
158. Triggs-Raine B, Salo TJ, Zhang H, Wicklow BA, Natowicz MR. 1999. Mutations in HYAL1, a member of a tandemly distributed multigene family encoding disparate hyaluronidase activities, cause a newly described lysosomal disorder, mucopolysaccharidosis IX. Proc Natl Acad Sci USA 96:6296-6300.
159. van Noort V, Worning P, Ussery DW, Rosche WA, Sinden RR. 2003. Strand misalignments lead to quasipalindrome correction. Trends Genet 19:365-369.
160. van Wijk E, Pennings RJ, te Brinke H, Claassen A, Yntema HG, Hoefsloot LH, Cremers FP, Cremers CW, Kremer H. 2004. Identification of 51 novel exons of the Usher syndrome type 2A (USH2A) gene that encode multiple conserved functional domains and that are mutated in patients with Usher syndrome type II. Am J Hum Genet 74:738-744.
161. Vidal V, Bay JO, Champomier F, Grancho M, Beauville L, Glowaczower C, Lemery D, Ferrara M, Bignon YJ. 1998. The 1396del A mutation and a missense mutation or a rare polymorphism of the WRN gene detected in a French Werner family with a severe phenotype and a case of an unusual vulvar cancer. Mutations in brief no. 136. Online. Hum Mutat 11:413-414.
162. Vithana EN, Morgan P, Sundaresan P, Ebenezer ND, Tan DT, Mohamed MD, Anand S, Khine KO, Venkataraman D, Yong VH, Salto-Tellez M, Venkatraman A, Guo K, Hemadevi B, Srinivasan M, Prajna V, Khine M, Casey JR, Inglehearn CF, Aung T. 2006. Mutations in sodium-borate cotransporter SLC4A11 cause recessive congenital hereditary endothelial dystrophy (CHED2). Nat Genet 38:755-757.
163. Walon C, Kartheuser A, Michils G, Smaers M, Lannoy N, Ngounou P, Mertens G, Verellen-Dumoulin C. 1997. Novel germline mutations in the APC gene and their phenotypic spectrum in familial adenomatous polyposis kindreds. Hum Genet 100:601-605.
164. Wang J, Gonzalez KD, Scaringe WA, Tsai K, Liu N, Gu D, Li W, Hill KA, Sommer SS. 2007. Evidence for mutation showers. Proc Natl Acad Sci USA 104:8403-8408.
165. Warner LE, Shohat M, Shorer Z, Lupski JR. 1997. Multiple de novo MPZ (P0) point mutations in a sporadic Dejerine-Sottas case. Hum Mutat 10:21-24.
166. Westerman AM, Entius MM, Boor PP, Koole R, de Baar E, Offerhaus GJ, Lubinski J, Lindhout D, Halley DJ, de Rooij FW, Wilson JH. 1999. Novel mutations in the LKB1/STK11 gene in Dutch Peutz-Jeghers families. Hum Mutat 13:476-481.
167. Whitelaw CM, Anwar S, Ades LC, Gole GA, Elder JE, Savarirayan R. 2004. Primary trabeculodysgenesis in association with neonatal Marfan syndrome. Am J Med Genet A 128A:418-421.
168. Wilkie AO, Patey SJ, Kan SH, van den Ouweland AM, Hamel BC. 2002. FGFs, their receptors, and human limb malformations: clinical and molecular correlations. Am J Med Genet 112:266-278.
169. Wimmer K, Roca X, Beiglbock H, Callens T, Etzler J, Rao AR, Krainer AR, Fonatsch C, Messiaen L. 2007. Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 50 splice-site disruption. Hum Mutat 28:599-612.
170. Wolf B, Jensen KP, Barshop B, Blitzer M, Carlson M, Goudie DR, Gokcay GH, Demirkol M, Baykal T, Demir F, Quary S, Shih LY, Pedro HF, Chen TH, Slonim AE. 2005. Biotinidase deficiency: novel mutations and their biochemical and clinical correlates. Hum Mutat 25:413.
171. Yokoi H, Makita N, Sasaki K, Takagi Y, Okumura Y, Nishino T, Makiyama T, Kitabatake A, Horie M, Watanabe I, Tsutsui H. 2005. Double SCN5A mutation underlying asymptomatic Brugada syndrome. Heart Rhythm 2:285-292.
172. Zenker M, Horn D, Wieczorek D, Allanson J, Pauli S, van der Burgt I, Doerr HG, Gaspar H, Hofbeck M, Gillessen-Kaesbach G, Koch A, Meinecke P, Mundlos S, Nowka A, Rauch A, Reif S, von Schnakenburg C, Seidel H, Wehner LE, Zweier C, Bauhuber S, Matejas V, Kratz CP, Thomas C, Kutsche K. 2007. SOS1 is the second most common Noonan gene but plays no major role in cardio-faciocutaneous syndrome. J Med Genet 44:651-656.
173. Zuker M. 2003. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 31:3406-3415.